Fortis Healthcare

ndtv | May 06, 2016

Shares of companies promoted by Malvinder Mohan Singh and Shivinder Mohan Singh came under selling pressure on Friday, following a Rs 2,600 crore penalty imposed on the billionaire brothers in a 2008 deal involving the sale of Ranbaxy to Daiichi Sankyo. (Read) Fortis Healthcare shares fell nearly 5 per cent on Friday, while Religare Enterprises shares traded 1 per cent lower. Both Fortis and Religare shares were headed for a fourth straight day of losses....

| May 27, 2016

NEW DELHI: Indian healthcare company Fortis Healthcare is set to turn its diagnostic chain SRL Diagnostics into a separate unit prior to getting it listed, thus providing an exit route to private equity investors, said two people familiar with the development. SRL Diagnostics had appointed Moelis & Co. advisor last year as part of efforts to give PE firms such as International Finance Corporation, NYLIM Jacob Ballas and Avigo Capital Partners an exit......

| May 26, 2016

NEW DELHI: Fortis Healthcare, one of the leading Indian healthcare chain is set to vertically demerge its diagnostic chainSRL Diagnostics that will help the company getting listed on the Indian bourses. The move aimed at giving an exit route to the private equity Investors, who together own 34% stake in the company, two people familiar with the development said......

Bloomberg | December 14, 2018

The Supreme Court today ordered a status quo on the Rs 4,000 crore sale of Fortis Healthcare Ltd. to Malaysian group IHH Healthcare Bhd. A three-judge bench headed by Justice Ranjan Gogoi was hearing the petition filed by Japanese drugmaker Daiichi Sankyo alleging former promoters—brothers Malvinder and Shivinder Singh—violated undertakings and court orders. Daiichi had sought a stay on the Fortis sale as the Singh brothers had not fulfilled their commitment to pay the drugmaker as p...